Evidence map›Paper›PMID 38544862›Full record

ArticleFrontiers in microbiology2024

A multiplex TaqMan real-time PCR assays for the rapid detection of mobile colistin resistance (

Xinran Gong, Guang Yang, Wei Liu, Di Wu, Chunyuan Duan, Xinjing Jia, Zhiqiang Li, Xiaocang Zou, Renfeng Yu, Dayang Zou and 1 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Xinran Gong *School of Public Health, China Medical University, Shenyang, China.
Guang Yang *The 5th Medical Center of General Hospital of Chinese People's Liberation Army, Beijing, China.
Wei Liu *Chinese PLA Center for Disease Control and Prevention, Beijing, China.
Di WuSchool of Public Health, China Medical University, Shenyang, China.
Chunyuan DuanSchool of Public Health, China Medical University, Shenyang, China.
Xinjing JiaSchool of Public Health, China Medical University, Shenyang, China.
Zhiqiang LiSchool of Public Health, China Medical University, Shenyang, China.
Xiaocang ZouChinese PLA Center for Disease Control and Prevention, Beijing, China.
Renfeng YuChinese PLA Center for Disease Control and Prevention, Beijing, China.
Dayang ZouChinese PLA Center for Disease Control and Prevention, Beijing, China.
Yong WangSchool of Public Health, China Medical University, Shenyang, China.
China Medical University · CNBeijing University of Chinese Medicine · CNChinese People's Liberation Army · CNNational Institute for Communicable Disease Control and Prevention · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Recently, 10 plasmid-mediated mobile colistin resistance genes, Methods: The primers and corresponding TaqMan-MGB probes were designed based on the sequence characteristics of all reported MCR family genes, multiplex Taqman-MGB probe-based qPCR assays were developed and optimized, and the sensitivity, specificity and reproducibility of the method were evaluated. The assay contained 8 sets of primers and probes in 4 reaction tubes, each containing 2 sets of primers and probes. Results: The standard curves for both the single and multiplex systems showed good linearity (R Conclusion: The assay developed in this study has the advantages of high specificity, sensitivity, and reproducibility. It can be used to specifically detect drug-resistant clinical isolates carrying the

Indexed as

colistinmultidrug-resistantmultiplex TaqMan real-time PCRrapid detectionthe mcr genes

Identifiers

PMID38544862
PMCPMC10967403
OpenAlexW4392749073

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.